|
|
Volumn 77, Issue SUPPL. 4, 1998, Pages 18-20
|
|
Advances in the management of malignancy-associated hyperuricaemia
|
|
Author keywords
Acute tumour lysis syndrome; Allopurinol; Hyperuricaemia; SR29142; Urate oxidase; Uric acid levels
|
|
Indexed keywords
ALLOPURINOL;
CALCIUM ION;
COMPLEMENTARY DNA;
DIURETIC AGENT;
HYPOXANTHINE;
PHOSPHATE;
POTASSIUM ION;
RECOMBINANT ENZYME;
RECOMBINANT URATE OXIDASE;
UNCLASSIFIED DRUG;
URATE OXIDASE;
URIC ACID;
URICOZYME;
XANTHINE;
XANTHINE OXIDASE;
ACUTE KIDNEY FAILURE;
ACUTE LEUKEMIA;
ANAPHYLAXIS;
ASPERGILLUS FLAVUS;
B CELL LYMPHOMA;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
ENZYME INHIBITION;
HUMAN;
HYDROTHERAPY;
HYPERKALEMIA;
HYPERPHOSPHATEMIA;
HYPERURICEMIA;
HYPOCALCEMIA;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LYMPHOPROLIFERATIVE DISEASE;
NONHODGKIN LYMPHOMA;
NONHUMAN;
OLIGURIA;
PRIORITY JOURNAL;
SACCHAROMYCES CEREVISIAE;
ALLOPURINOL;
ANTINEOPLASTIC AGENTS;
ASPERGILLUS FLAVUS;
GOUT SUPPRESSANTS;
HUMANS;
MALE;
RECOMBINANT PROTEINS;
TUMOR LYSIS SYNDROME;
URATE OXIDASE;
URIC ACID;
|
|
EID: 0031839159
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1038/bjc.1998.432 Document Type: Article |
|
Times cited : (75)
|
|
References (6)
|
